What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NAS:VRTX Key Ratios
| Market Cap $ M | 112,644.09 |
| Enterprise Value $ M | 106,995.46 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 24.48 |
| Price/Book | 6.83 |
| Price/Sales | 10.25 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 11,099.00 |
| EPS (TTM) $ | -3.92 |
| Beneish M-Score | -1.4 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -11.60 |
| y-y EBITDA Growth Rate % | -101.80 |
| EV-to-EBIT | -386.27 |
| EV-to-EBITDA | -1,428.51 |
| PEG | -- |
| Shares Outstanding M | 256.80 |
| Net Margin (%) | -8.91 |
| Operating Margin % | 37.93 |
| Pre-tax Margin (%) | -2.71 |
| Quick Ratio | 2.29 |
| Current Ratio | 2.65 |
| ROA % (ttm) | -4.43 |
| ROE % (ttm) | -6.04 |
| ROIC % (ttm) | 111.68 |
| Dividend Yield % | -- |
| Altman Z-Score | 11.88 |
VRTX Number of Guru Trades
VRTX Volume of Guru Trades
Gurus Latest Trades with NAS:VRTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRTX is held by these investors
Total 6
Vertex Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:VRTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers